Literature DB >> 26141608

Fibrogenesis, novel lessons from animal models.

Ellen De Langhe1, Rik Lories.   

Abstract

Systemic sclerosis (SSc) is a devastating chronic autoimmune connective tissue disease characterized by vasculopathy, autoimmunity with inflammation, and progressive fibrogenesis. The current paradigm of the pathogenesis of SSc is that of an unknown initial trigger, leading to a complex interaction of immune cells, endothelial cells, and fibroblasts, producing cytokines, growth and angiogenic factors, and resulting in uncontrolled and persistent tissue fibrogenesis by an altered mesenchymal cell compartment. Animal models are of utmost importance to investigate the different steps in the pathogenesis. This review will elaborate on recent findings in established and more recently developed animal models, presenting data on compounds that are in or ready to be translated into clinical trials, or provide interesting new findings in the understanding of the pathophysiology of SSc. We focus on recent findings concerning the vessel-extracellular matrix interaction, the initial triggering aggressor, the concept of autoimmunity and inflammatory changes, the effector cells and their origins, and the complex interaction of the different signaling pathways in fibrogenesis.

Entities:  

Mesh:

Year:  2015        PMID: 26141608     DOI: 10.1007/s00281-015-0510-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  84 in total

1.  Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway.

Authors:  J Czuwara-Ladykowska; F Shirasaki; P Jackers; D K Watson; M Trojanowska
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

Review 2.  The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis.

Authors:  A L Herrick; M Matucci Cerinic
Journal:  Clin Exp Rheumatol       Date:  2001 Jan-Feb       Impact factor: 4.473

3.  Editorial: Fate of fat tissue adipocytes: do they transform into myofibroblasts in scleroderma?

Authors:  Galina S Bogatkevich
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

4.  Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.

Authors:  Jingang Huang; Christian Beyer; Katrin Palumbo-Zerr; Yun Zhang; Andreas Ramming; Alfiya Distler; Kolja Gelse; Oliver Distler; Georg Schett; Lutz Wollin; Jörg H W Distler
Journal:  Ann Rheum Dis       Date:  2015-04-09       Impact factor: 19.103

5.  Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion.

Authors:  P Sambo; L Jannino; M Candela; A Salvi; M Donini; S Dusi; M M Luchetti; A Gabrielli
Journal:  J Invest Dermatol       Date:  1999-01       Impact factor: 8.551

6.  Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.

Authors:  Amélie Servettaz; Claire Goulvestre; Niloufar Kavian; Carole Nicco; Philippe Guilpain; Christiane Chéreau; Vincent Vuiblet; Loïc Guillevin; Luc Mouthon; Bernard Weill; Frédéric Batteux
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation.

Authors:  Yoshihide Asano; Joanna Czuwara; Maria Trojanowska
Journal:  J Biol Chem       Date:  2007-09-19       Impact factor: 5.157

9.  Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.

Authors:  Britta Maurer; Alfiya Distler; Yossra A Suliman; Renate E Gay; Beat A Michel; Steffen Gay; Jörg H W Distler; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2013-08-05       Impact factor: 19.103

10.  Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.

Authors:  Yoshihide Asano; Margaret Markiewicz; Masahide Kubo; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

View more
  2 in total

1.  Multiorgan chronic inflammatory hepatobiliary pancreatic murine model deficient in tumor necrosis factor receptors 1 and 2.

Authors:  Helieh S Oz
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

2.  Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.

Authors:  Yael Aschner; Meghan Nelson; Matthew Brenner; Helen Roybal; Keriann Beke; Carly Meador; Daniel Foster; Kelly A Correll; Paul R Reynolds; Kelsey Anderson; Elizabeth F Redente; Jennifer Matsuda; David W H Riches; Steve D Groshong; Ambra Pozzi; Jan Sap; Qin Wang; Dhaarmini Rajshankar; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-03       Impact factor: 5.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.